Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

AGM Trading Statement

28 Sep 2016 07:00

RNS Number : 9935K
PZ CUSSONS PLC
28 September 2016
 

28 September 2016

PZ Cussons Plc

(the "Group")

 

AGM Trading Statement

 

PZ Cussons Plc, a leading international consumer products group, today issues the following trading update which covers the period 1 June 2016 to 27 September 2016, in advance of its Annual General Meeting, to be held at 10:30 today.

 

Overview of financial performance and position

 

The board is pleased to announce that the overall performance of the Group during the period has been in line with expectations. The financial position of the Group remains strong with cash generation during the period also in line with expectations.

 

Trading Update

 

Europe

 

In the UK, performance in the washing and bathing division has been robust across the brand portfolio of Imperial Leather, Original Source and Carex with the Group's renovation and innovation strategy continuing to play an important role in holding or growing market shares in a competitive trading environment.

 

In the beauty division, a poor summer has adversely affected sales of St Tropez in the UK, however sales in the US have been particularly strong. A significant number of new product launches will take place across the portfolio of St Tropez, Sanctuary, Fudge and Charles Worthington over the remainder of the financial year.

 

Performance in the smaller markets of Poland and Greece has been in line with expectations.

 

Asia

 

In Australia, whilst tough trading conditions are evident in all channels, there is a strong new product pipeline in place for the remainder of the year across all categories of personal care, beauty, home care and food and nutrition.

 

In Indonesia, revenue growth has continued to be strong across both babycare and non-babycare portfolios and performance in the smaller markets of Thailand and the Middle East has been in line with expectations.

 

Asian results are also benefiting on translation to sterling as a result of the weaker pound.

 

Africa

 

In Nigeria, following the introduction of the new flexible exchange rate regime in June which led to a 40% devaluation of the naira, there has been some improvement in liquidity although the currency has continued to weaken on both the interbank and secondary markets.

 

Performance across personal care, home care, electricals and food and nutrition has been robust in the period. The Group's diverse brand portfolio with product offerings at all price points is working well in an environment where the consumer is under significant inflationary pressure.

 

Performance in the smaller markets of Ghana and Kenya has been in line with expectations.

 

Outlook

 

The strength of the Group's brand portfolio and new product pipeline is serving us well and, together with a continued focus on costs, leaves the Group well placed to manage the challenging trading conditions that exist in most markets.

 

The Group's balance sheet remains strong and well placed to pursue new opportunities as they arise.

 

A further trading update will be made on 15 December 2016.

 

 

Enquiries:

 

PZ Cussons Plc

Brandon Leigh

 

Tel: 0161 435 1236

Instinctif

Tim Linacre / Guy Scarborough

Tel: 020 7457 2020

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMEDLFLQKFXBBZ
Date   Source Headline
25th Sep 20193:57 pmRNSResult of AGM
25th Sep 20197:00 amRNSAGM Trading Statement
29th Aug 20197:00 amRNSProposed sale of Minerva and Luksja brand
23rd Aug 201912:15 pmRNSPublication of ARA and Notice of AGM
26th Jul 20198:45 amRNSDirector/PDMR Shareholding
23rd Jul 20197:00 amRNSFinal Results
13th Jun 20197:00 amRNSBoard Change
13th Jun 20197:00 amRNSTrading update
30th Apr 20195:30 pmRNSDirector/PDMR Shareholding
18th Apr 20197:00 amRNSTrading Update
28th Mar 201912:15 pmRNSDirector Declaration
14th Mar 201910:00 amRNSPZ Cussons Plc Director Declaration
30th Jan 201911:10 amRNSInterim Dividend Payment Date
29th Jan 20197:00 amRNSHalf-year Report
23rd Jan 20198:10 amRNSDirector Declaration
13th Dec 20187:00 amRNSTrading Update
13th Nov 201811:09 amRNSHolding(s) in Company
26th Sep 20184:25 pmRNSResult of AGM
26th Sep 20187:00 amRNSAGM Trading Statement
6th Aug 20185:30 pmRNSDirector/PDMR Shareholding
30th Jul 20185:19 pmRNSDirector/PDMR Shareholding
26th Jul 20184:05 pmRNSDirector/PDMR Shareholding
26th Jul 20183:15 pmRNSDirector/PDMR Shareholding
24th Jul 20187:00 amRNSFinal Results
14th Jun 20187:00 amRNSTrading update
2nd May 20187:00 amRNSChange to the Board of Directors
15th Mar 20187:00 amRNSTrading Update
30th Jan 20187:00 amRNSInterim Results
4th Jan 20184:41 pmRNSDirectorate Change
14th Dec 20177:00 amRNSTrading Update
7th Dec 201710:42 amRNSHolding(s) in Company
5th Dec 201710:49 amRNSHolding(s) in Company
27th Sep 20175:30 pmRNSAGM Statement
27th Sep 20177:00 amRNSAGM Trading Statement
30th Aug 20175:30 pmRNSDirector/PDMR Shareholding
28th Jul 20175:30 pmRNSHolding(s) in Company
27th Jul 201711:03 amRNSDirector/PDMR Shareholding
25th Jul 20177:01 amRNSBoard Changes
25th Jul 20177:00 amRNSFinal Results
15th Jun 20177:00 amRNSTrading Update
13th Apr 20177:00 amRNSTrading Update
24th Mar 20177:00 amRNSAppointment of Deloitte LLP as Auditor
13th Mar 201712:24 pmRNSDirector/PDMR Shareholding
1st Feb 20178:45 amRNSDirector/PDMR Shareholding
26th Jan 20175:30 pmRNSDirector/PDMR Shareholding
25th Jan 20175:30 pmRNSDirector/PDMR Shareholding
24th Jan 20177:00 amRNSHalf-year Report
15th Dec 20167:00 amRNSTrading Update
12th Oct 20167:00 amRNSAppointment of a new Non-executive Director
3rd Oct 20164:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.